Infectious Disease Diagnostics Market will Explore Robust Size & Growth During 2018-2026
Infectious
diseases are caused by organisms such as bacteria, viruses,
fungi, and parasites and are capable of transmission from one species
to another species. Diagnosis of these diseases involves identifying
the pathogen and its type and the degree up to which the infection
has spread. Infectious diseases such as HIV, tuberculosis, malaria,
and Influenza are highly prevalent and can be efficiently diagnosed
with the help of diagnostic tests available for the respective
diseases.
Technologies utilized by these diagnostic tests
are classified into biochemical techniques, molecular techniques,
immunodiagnostics, and conventional culturing, and staining
techniques. Biochemical techniques include ELISA, agglutination, and
others, while molecular techniques include Polymerase Chain Reaction
(PCR) and Next-Generation Sequencing techniques. These tests are
capable of diagnosing the infectious diseases accurately with high
throughput capacity.
Advances in molecular testing techniques have
resulted in fast diagnosis of infectious diseases in real-time due to
which patients can receive treatment early. Commercially available
diagnostic tests include BD Max Smart Cycler, GeneXpert, BD Phoenix
CPO detect test, Xpert Xpress Strep A, and BioPlex 2200 Syphilis
Total & RPR Assay.
Partnerships and collaborations by market
players to develop novel diagnostic techniques is expected to boost
growth of the infectious disease diagnostics market
Individual organizations, manufacturers, and
research institutes are forming partnerships, and collaborations to
advance research and development of diagnostic tests for infectious
diseases. Moreover, funding by individual organizations to advance
research is expected to boost the growth of the market over the
forecast period. For instance, the University of Virginia’s Global
Infectious Diseases Institute funded seven projects designed to
tackle challenging problems in infectious diseases worldwide in July
2018. They have formed collaborative teams across diverse academic
disciplines to control and treat Zika virus infections and to reduce
tuberculosis rates among HIV-infected patients in Africa.
The New York Governor’s Office announced a
research collaboration with Regeneron Pharmaceuticals, Inc. to
advance the diagnosis and treatment of tick-borne diseases in June
2018. Moreover, Infectious Diseases Society of America (IDSA) and
American Society for Microbiology (ASM) released a guide in July
2018, which is expected to help healthcare providers to understand
latest technology trends, and knowledge on when to order which test.
These factors are expected to affect the growth of infectious disease
diagnostic market over the forecast period.
Global Key Players:
Key companies covered as a part of this study
include Danaher Corporation, Abbott Laboratories, Becton, Dickinson,
and Company, F. Hoffmann La-Roche Ltd., Trinity Biotech Plc, Cardinal
Health, Inc., BioMérieux, Bio-Rad Laboratories, Inc., AccuBioTech
Co., Ltd., and Acon Laboratories, Ltd.
Ask For Discount Before Purchasing This Business
Report @
https://www.coherentmarketinsights.com/insight/request-discount/1971
Detailed Segmentation:
-
Global Infectious Disease Diagnostics Market, By Product Type:
-
Kits & Reagents
-
Instruments
-
-
Global Infectious Disease Diagnostics Market, By Disease Type:
-
HIV
-
Hepatitis
-
Healthcare Associated Infections (HAIs)
-
Human Papillomavirus (HPV)
-
Tuberculosis (TB)
-
Influenza
-
Others
-
-
Global Infectious Disease Diagnostics Market, By Technology:
-
Immunodiagnostics
-
Polymerase Chain Reaction (PCR)
-
Next Generation Sequencing (NGS)
-
Others
-
-
Global Infectious Disease Diagnostics Market, By Test Location:
-
Laboratory Testing
-
Point-of-Care Testing
-
-
Global Infectious Disease Diagnostics Market, By End User:
-
Hospitals
-
Pathology/Diagnostic Laboratories
-
Research Institutes
-
Home-Care Settings
-
Others
-
-
Global Infectious Disease Diagnostics Market, By Geography:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East
-
Africa
-
North America
About Coherent
Market Insights
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market
Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702

Comments
Post a Comment